HLIB Research retains overweight on glove makers


Vaccination demand for gloves to more than offset the decline from testing demand.

KUALA LUMPUR: Hong Leong Investment Bank (HLIB) Research is retaining its overweight stance on glove makers as it sees demand and average selling prices (ASPs) will be driven by testing frequency and vaccine rollout using gloves.

In its research note on Tuesday, it said for the remainder of CY21, it expects vaccination demand for gloves to more than offset the decline from testing demand.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

HLIB Research , gloves , Top Glove , vaccine

   

Next In Business News

Dutch Lady’s 3Q24 net profit rises
Bank Negara committed to supporting country’s cash economy
Innovation, collaboration key to drive market resilience
TCS bags Sabah Pan Borneo Highway deal
New launches poised to propel Matrix Concepts
India to sell minority stakes in state banks
Dialog quarterly bottom line rises 14%
Cape EMS registers loss-making third quarter
Eden wins RM20mil govt contract
Beijing says its capital market will continue opening up

Others Also Read